Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-AIM: an unexpected success story

Tue, 04th May 2021 09:29

* European shares flat

* Mining and travel stocks lift by recovery hopes

* Britain to announce green list of holiday countries

May 4 - Welcome to the home for real-time coverage of
markets brought to you by Reuters reporters. You can share your
thoughts with us at markets.research@thomsonreuters.com

AIM: AN UNEXPECTED SUCCESS STORY (0822 GMT)

London's junior market has weathered the pandemic storm
quite gracefully, with only seven companies leaving AIM due to
financial stress or insolvency in 2020, while businesses have
become attractive M&A targets.

According to data from UHY Hacker Young Group, the figure is
a record low and an astonishing success compared to 82 during
that left after the global financial crisis in 2009. (See UHY
data in the chart)

"The pandemic year has turned into an unexpected success
story for AIM," Daniel Hutson, Partner at UHY Hacker Young.

This is because, compared with the previous financial
crisis, more AIM companies are in the later stage in their
development and in the position to ask for support from
shareholders during stressful times, UHY says.

Better corporate governance also played a role in keeping
these companies away from trouble, UHY adds.

Another sign that the AIM market managed relatively well
during the pandemic is the fact that M&A deals are staging a
comeback.

In the six months to March 2021, 15 AIM M&A deals were
completed, compared to just seven in the previous six months,
UHY data shows.

Big deals in 2021 included the 650 million pounds
acquisition of Applegreen by a Blackstone-led consortium, and
the 860 million pounds purchase of game developer Codemasters by
Electronic Arts.

"It is also encouraging to see that the M&A deals in recent
months have been growth acquisitions by PE and trade buyers
rather than purchases of distressed assets".

(Joice Alves)

*****

EUROPE SUPPORTED BY RECOVERY BETS, LONDON CATCHES UP

European shares open in positive territory with economy
sensitive sectors leading the way on hopes for recovery, while
London outperforms after an extended weekend.

Investors are betting on a strong global rebound helped by
massive stimulus and ongoing vaccination programmes in developed
countries.

Heavyweight oil majors BP and Royal Dutch Shell
are providing the biggest boost to the FTSE.

The pan European index started the day slightly up
and was last flat, with miners and oil and gas
indexes rising 0.6% and 0.8%, respectively.

Among top performers, travel and leisure sector rose
as it is benefiting from Britain's expected announcement of a
green list for countries that people can travel to on holidays.

(Joice Alves)

*****

DRIVING DOWN THE RECOVERY HIGHWAY (0658 GMT)

With the U.S. economic recovery story firmly entrenched into
the market mindset, Monday's softer-than-expected U.S.
manufacturing report pushed Treasury yields lower and toppled
the dollar from multi-week highs. On the other hand, there were
upbeat earnings, news of cities reopening, and a dovish Federal
Reserve, all of which are keeping the tone relatively positive.

What's more, the data from the Institute of Supply
Management (ISM) showed that rising costs and capacity pressures
undermined output rather than any hit to demand. South Korean
export data and German retail sales figures have broadly
confirmed that trend.

Until U.S. services data and monthly payrolls numbers offer
further guidance later this week, markets are scratching around
in well-worn ranges; the dollar is a touch firmer and U.S. stock
futures are treading water.

Meanwhile, Australia kicked off a busy week for central
banks. It kept policy rates unchanged but upped economic
forecasts. Norway, UK, Turkey and Brazil will also announce
monetary policy decisions this week, with many expecting the
Bank of England to announce a cut to its bond-buying QE.

In corporate news, Italy's Mediaset and its second-largest
investor, Vivendi ended years of legal sparring, agreeing for
the French group to cut its stake in the Italian broadcaster.
Shares in travel and leisure firms such as TUI, Carnival and
EasyJet are up in pre-market on news the EU will ease travel
curbs on vaccinated holidaymakers.

But don't forget the virus. India's infections caseload
surged past 20 million, the second nation after the United
States to pass the milestone. And a sudden spurt in Taiwan's
infections numbers pushed shares there 3% lower.
Key developments that should provide more direction to markets
on Tuesday:

-Corporate news: Verizon is ditching its media businesses
that include iconic brands Yahoo and AOL for $5 billion; German
meal-kit delivery company HelloFresh grew its active customer
base by 74% in Q1; Norway's Telenor has written off the value of
its Myanmar operation.

-UK April final PMI readings

-Bank of France Governor Villeroy speaks

-U.S., Canada March trade data

-Dallas Fed President Robert Kaplan to speak. He caused a
stir on Friday by calling for a conversation about tapering.

-China Caixin PMI final

-US durable goods/factory orders

-US earnings: Thomson Reuters, Pfizer, ConocoPhilips,
Western Union, Herbalife, Prudential

(Saikat Chatterjee)

EUROPEAN BOURSES LOOKING FOR RECOVERY SIGNALS (0538 GMT)

European bourses are seen open little changed mirroring
Asian shares as investors look for signs of recovery as major
economies around the world reopen.

The mildly positive tone in Asia was broadly in line with
that on Wall Street overnight, where upbeat earnings, news of
cities reopening and a dovish Federal Reserve helped offset a
disappointing report on manufacturing activity.

In the corporate news, Italy's Mediaset and its
second-largest investor, Vivendi, on Monday ended years of legal
sparring with an accord under which the French group will
drastically cut its stake in the Italian broadcaster.

(Joice Alves)

****

More News
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.